Editorial
Published on 26 Sep 2024
Editorial: Developing next-generation therapeutics to defeat mutation-driven cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1487952
- 552 views
Type at least 3 characters
7,231 articles
Articles
Review
Published on 26 Sep 2024
Immunomodulatory effects of immune cell-derived extracellular vesicles in melanoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1442573
- 1,727 views
Original Research
Published on 26 Sep 2024
Genetically predicted Caspase 8 levels mediates the causal association between CD4+ T cell and breast cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1410994
- 1,588 views
Original Research
Published on 26 Sep 2024
Causal effect of thyroid cancer on secondary primary malignancies: findings from the UK Biobank and FinnGen cohorts
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1434737
- 2,556 views
Original Research
Published on 26 Sep 2024
Cardiovascular adverse events associated with targeted therapies for multiple myeloma: a pharmacovigilance study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1400101
- 1,533 views
Original Research
Published on 25 Sep 2024
Selected stem cell populations in pediatric acute lymphoblastic leukemia
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1446687
- 1,363 views
Original Research
Published on 25 Sep 2024
Metabolite, immunocyte phenotype, and lymphoma: a Mendelian randomization study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1431261
- 2,933 views
Original Research
Published on 25 Sep 2024
Higher frequency of peripheral blood CD103+CD8+ T cells with lower levels of PD-1 and TIGIT expression related to favorable outcomes in leukemia patients
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1437726
- 1,686 views
Review
Published on 25 Sep 2024
Galectin-9 – ligand axis: an emerging therapeutic target for multiple myeloma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1469794
- 1,749 views
- 2 citations
Retraction
Published on 25 Sep 2024
Retraction: CCDC88A post-transcriptionally regulates VEGF via miR-101 and subsequently regulates hepatocellular carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1495479
- 526 views
Case Report
Published on 25 Sep 2024
Case report: sub-clinical extramedullary B-ALL in the setting of relapse following targeted therapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1423487
- 1,882 views
Mini Review
Published on 25 Sep 2024
Cross-omics strategies and personalised options for lung cancer immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1471409
- 1,614 views
- 2 citations
Editorial
Published on 24 Sep 2024
Editorial: Treating solid organ diseases with innovative chimeric-antigen receptor T-cells: current indications, progress, limitations and potential strategies
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1491982
- 541 views
Original Research
Published on 24 Sep 2024
Novel prognostic signature for hepatocellular carcinoma using a comprehensive machine learning framework to predict prognosis and guide treatment
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1454977
- 2,504 views
Systematic Review
Published on 24 Sep 2024
Global research trends and focus on the link between neutrophil extracellular traps and tumor: a bibliometric and visualization analysis from 2006 to 2024
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1452104
- 2,372 views
- 1 citation
Original Research
Published on 24 Sep 2024
Machine learning-based discovery of UPP1 as a key oncogene in tumorigenesis and immune escape in gliomas
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1475206
- 1,597 views
- 1 citation